Results 211 to 220 of about 276,580 (388)

Childhood gastroesophageal reflux disease. [PDF]

World J Clin Pediatr
Pandey A.
europepmc   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan, Jason C. Hsu, Christine Y. Lu   +2 more
wiley   +1 more source

Endoscopic assessment of the gastroesophageal junction for predicting gastroesophageal reflux disease. [PDF]

J Int Med Res
Fan X, Xu W, Zhang L, Shi Y, Li Y, Lin X.   +5 more
europepmc   +1 more source

Dietary Strategies and Nutritional Management in Patients Receiving GLP‐1 and Dual GIP/GLP‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and dual GIP/GLP‐1 RAs are widely used to manage obesity, prediabetes and type 2 diabetes, typically in combination with lifestyle interventions. Their nutritional implications, however, remain unclear.
Rayanne Santos de Paulo, Dandara Baia Bonifácio, Matheus Henrique Lana de Carvalho, Josefina Bressan   +3 more
wiley   +1 more source

Is gastroesophageal reflux linked to inflammation-related gestational complications and poor obstetric history? [PDF]

BMC Pregnancy Childbirth
Beksac K, Donmez HG, Cagan M, Fadiloglu E, Beksac MS.   +4 more
europepmc   +1 more source

CPAP-induced Aerophagia May Precipitate Gastroesophageal Reflux [PDF]

, 2013
Kelly Shepherd, David R. Hillman, Peter R. Eastwood   +2 more
openalex   +1 more source

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3‐Month results from the TRIUMPH study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To compare the 3‐month effectiveness of galcanezumab with select traditional oral migraine preventive (TOMP) medications recommended by scientific societies (TOMP efficacy subset) and with the most frequently used individual TOMP medications.
Shivang Joshi, Cristina Tassorelli, Manjit Matharu, Taoufik Alsaadi, Carlos Vallarino, Lars Viktrup, Maurice Vincent, Rebecca L. Robinson   +7 more
wiley   +1 more source

Diagnostic accuracy of gastric filling ultrasound combined with BMI for gastroesophageal reflux disease. [PDF]

Front Med (Lausanne)
Tang F, Yu H, Zhao T, Lin L, Dong P, Sun K, Sun X, Wang Q.   +7 more
europepmc   +1 more source

Adenotonsillectomy improves gastroesophageal reflux, sleep and quality of life in children with obstructive sleep apnea syndrome - a pilot study

, 2013
Alessandra Caland Noronha, Veralice Meireles Sales de Bruin, Pedro Felipe Carvalhedo de Bruin, Miguel Angelo N. Souza, Roberta de Paula Araújo, Rosa Maria Salani Mota, Marcos Rabelo de Freitas   +6 more
openalex   +1 more source

Caspase-Dependent Activation of Cascade Cytokines in Young Patients With Autoimmune Thyroiditis in Combination With Gastroesophageal Reflux Disease

, 2021
T. M. Pasiieshvili, Л. М. Пасієшвілі, Natalia Zhelezniakova, Olga Kovalyova   +3 more
openalex   +1 more source